Vistagen Therapeutics, Inc. Common Stock
$0.578
USD
Last updated on --.
24h volume677.97K
24h highest0.61000 USD
24h lowest0.56000 USD
24h Price movement+0.86%
VTGN recent prices
24 Hours
+0.86%+$0.0049
30 days
-9.62%-$0.0626
60 days
-2.00%-$0.012
90 days
-6.70%-$0.0422
Key data
Previous close0.57310 USD
Market cap21.55M USD
Volume677.97K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.3500 USD
Net income (FY)-53.41M USD
Revenue (FY)805.00K USD
Last report dateFeb 12, 2026
About Vistagen Therapeutics, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)59.00
Revenue per employee (FY)13.64K USD
Net income per employee (FY)-905.27K USD
Listed onNasdaq
VTGN conversion tables
 |  |
|---|---|
| 0.5 VTGN | 0.289 USD |
| 1 VTGN | 0.578 USD |
| 5 VTGN | 2.890 USD |
| 10 VTGN | 5.780 USD |
| |
|---|---|
| 0.5 USD | 0.86505 VTGN |
| 1 USD | 1.730 VTGN |
| 5 USD | 8.650 VTGN |
| 10 USD | 17.3 VTGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VTGN is trading at $0.578, +0.86% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VTGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VTGN is currently trading at $0.578, +0.86% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VTGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VTGN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VTGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VTGN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Vistagen Therapeutics, Inc. Common Stock's market cap is currently 21.55M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume677.97K
24h highest0.61000 USD
24h lowest0.56000 USD
24h Price movement+0.86%
Start trade with VTGN Perpetual
Sign up to trade